Your browser doesn't support javascript.
loading
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial.
Becker, Frauke; Dakin, Helen A; Reed, Shelby D; Li, Yanhong; Leal, José; Gustavson, Stephanie M; Wittbrodt, Eric; Hernandez, Adrian F; Gray, Alastair M; Holman, Rury R.
Afiliação
  • Becker F; Health Economics Research Centre, University of Oxford, Oxford, UK.
  • Dakin HA; Health Economics Research Centre, University of Oxford, Oxford, UK. Electronic address: helen.dakin@ndph.ox.ac.uk.
  • Reed SD; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
  • Li Y; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
  • Leal J; Health Economics Research Centre, University of Oxford, Oxford, UK.
  • Gustavson SM; AstraZeneca Research and Development, Gaithersburg, MD, USA.
  • Wittbrodt E; AstraZeneca Research and Development, Gaithersburg, MD, USA.
  • Hernandez AF; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
  • Gray AM; Health Economics Research Centre, University of Oxford, Oxford, UK.
  • Holman RR; Diabetes Trials Unit, University of Oxford, Oxford, UK.
Diabetes Res Clin Pract ; 183: 109152, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34813910
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Diabetes Res Clin Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Diabetes Res Clin Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido